tiprankstipranks
3 Best Stocks to Buy Now, 5/22/2024, According to Top Analysts 
Market News

3 Best Stocks to Buy Now, 5/22/2024, According to Top Analysts 

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating recently and has a significant upside as well. 

Don't Miss our Black Friday Offers:

To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts. 

Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio. 

Jasper Therapeutics (NASDAQ:JSPR) –  Jasper Therapeutics is a biotechnology company that develops mast cells and stem cells to treat chronic diseases. Yesterday, TD Cowen analyst Yaron Werber reiterated a Buy rating on the stock. In the last three months, all three Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 224%.

Evolus (NASDAQ:EOLS) –  This is a global performance beauty company. Yesterday, H.C. Wainwright Analyst Douglas Tsao maintained a Buy rating on the stock with a price target of $27 per share. In the last three months, all five Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 76%. 

Vir Biotechnology (NASDAQ:VIR) – This is a commercial-stage immunology company. Yesterday, Barclays Analyst Gena Wang assigned a Buy rating on the stock with a price target of $27 per share. Interestingly, three out of the five Top Analysts who recently rated the stock gave it a Buy. Taken together, their 12-month price targets imply an upside of about 118%. 

Who are the Top Analysts? 

TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time. 

See real-time analyst rankings and learn more about the performance of Top Analysts on TipRanks’ Top Wall Street Analysts page. 

Disclosure 

Related Articles
TheFlyVir Biotechnology holds a virtual investor update
TheFlyVir Biotechnology announces results from SOLSTICE trial
TheFlyVir Biotechnology gets positive opinion on orphan drug designation for Tobevibar
Go Ad-Free with Our App